Hospital Discharges for Prescription Opioids Have Fallen

This article originally appeared here.
Share this content:
Hospital Discharges for Prescription Opioids Have Fallen
Hospital Discharges for Prescription Opioids Have Fallen

TUESDAY, Oct. 3, 2017 (HealthDay News) -- Prescription opioid-related inpatient and emergency department (ED) discharges have decreased since 2010, while heroin-related discharges have increased sharply since 2008, according to a study published online Oct. 2 in Health Affairs.

Dario Tesdesco, Ph.D., from Stanford University in California, and colleagues examined national trends in inpatient and emergency department discharges for opioid abuse, dependence, and poisoning using data from the Healthcare Cost and Utilization Project for 1997 to 2014 (inpatient discharges) and for 2006 to 2014 (ED discharges).

The researchers found that there was an increase in overall opioid-related inpatient and ED discharge rates in the U.S. population. Starting in 2010, prescription opioid-related discharges decreased, coinciding with national, state, and local initiatives. There was a sharp increase in heroin-related discharges starting in 2008.

"The decrease in prescription opioid-related discharges gives hope that health care providers, nonmedical first responders, and families are appropriately responding to safety initiatives," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »